More Enorama Pharma AB news
Enorama Pharma ABOMXSTO: ERMA

Enorama Pharma Reports Q4 Net Sales Of SEK 1.75 Million

Mar 18, 2026 at 4:23 AM EDT · Issued by Enorama Pharma AB

On 6ix: 6ix.com/news/enorama-pharma-reports-q4-net-sales-of-sek-1.75-million

Enorama Pharma AB OMXSTO:ERMA:

  • Q4 2025 NET SALES AMOUNT TO 1,750 KSEK

  • Q4 2025 OPERATING RESULT AMOUNTS TO -18,472 KSEK

Enorama Pharma AB on 6ix

Earlier from Enorama Pharma

  • Balance Sheet For Liquidation Purposes Shows Enorama Pharma Equity Is Less Than Half Of Registered Share CapitalMar 11
  • Enorama Pharma Postpones Publication Of 2025 Report Due To Control Balance SheetMar 10
  • Enorama Pharma AB (publ) resolves to postpone the planned extraordinary general meetingMar 3
  • Enorama Pharma Enters Loan Agreement With DS GlobalFeb 18
  • Enorama Pharma Postpones Its 2025 Year-End ReportFeb 13

Later from Enorama Pharma

  • Enorama Pharma: PRESS RELEASE FROM THE EXTRAORDINARY GENERAL MEETING, AND FIRST CONTROL MEETING, IN ENORAMA PHARMA AB (PUBL)Apr 7
  • Enorama Pharma Q1 Operating Loss Narrows To SEK 10.9 MlnMay 20
  • Enorama Pharma: bulletin from the annual general meeting of Enorama Pharma AB (publ)Jun 16
All Enorama Pharma news releases↗

Follow Enorama Pharma into a list and get an email when it puts out news.

Follow Enorama Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer